Views & analysis - Pharmaphorum

Trending

Latest Views & analysis

in Views and analysis
Beyond patient centricity – supporting the support network
August 13, 2018 Share
X
Beyond patient centricity – supporting the support network
https://pharmaphorum.com/views-and-analysis/beyond-patient-centricity-support-network/
in Views and analysis
Holidaymakers to access GPs through new app
August 10, 2018 Share
X
Holidaymakers to access GPs through new app
https://pharmaphorum.com/views-and-analysis/holidaymakers-to-access-gps-through-new-app/
in Views and analysis
Brexit from the inside: MP’s views on how it will impact pharma
August 9, 2018 Share
X
Brexit from the inside: MP’s views on how it will impact pharma
https://pharmaphorum.com/views-and-analysis/brexit-inside-mps-views-impact-pharma/
in Views and analysis
Why AI and blockchain are the solutions to developing orphan drug
August 8, 2018 Share
X
Why AI and blockchain are the solutions to developing orphan drug
https://pharmaphorum.com/views-analysis-digital/blockchain-solution-developing-orphan-drug/

Brexit from the inside: MP’s views on how it will impact pharma

Brexit from the inside: MP’s views on how it will impact pharma

With the potential for a hard-no-deal Brexit becoming closer to reality with each passing day, the question of

X

Brexit from the inside: MP’s views on how it will impact pharma

https://pharmaphorum.com/views-and-analysis/brexit-inside-mps-views-impact-pharma/

Why AI and blockchain are the solutions to developing orphan drug

Why AI and blockchain are the solutions to developing orphan drug

We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing

X

Why AI and blockchain are the solutions to developing orphan drug

https://pharmaphorum.com/views-analysis-digital/blockchain-solution-developing-orphan-drug/

Curious2018: A thirst for innovation

Curious2018: A thirst for innovation

All too often pharma companies are accused of putting shareholders before their patients and society as a whole.

X

Curious2018: A thirst for innovation

https://pharmaphorum.com/views-and-analysis/curious2018-innovation-thirst/

Recommended authors

More Views & Analysis

Digital health as a complementary therapy

Digital health as a complementary therapy

For years, digital health has been heralded as the saviour of health services and the answer to patient

X

Digital health as a complementary therapy

https://pharmaphorum.com/digital/digital-health-as-a-complementary-therapy/

Division on European HTA

Division on European HTA

There have been aspirations for closer collaboration between European Union (EU) Member States (MS) on Health Technology Assessment

X

Division on European HTA

https://pharmaphorum.com/views-and-analysis/hta-european-health-technology-assessment-division-progress/

Oncolytics: the dawn of a new era in cancer treatment

Oncolytics: the dawn of a new era in cancer treatment

Oncolytic virus therapy is not a new discovery, but it may now be positioned as the next major

X

Oncolytics: the dawn of a new era in cancer treatment

https://pharmaphorum.com/views-and-analysis/oncolytics-new-era-cancer-treatment/

Johnson & Johnson leads the way to a world without disease

Johnson & Johnson leads the way to a world without disease

Cat Oyler, Global Head of External Innovation Strategy and Operations at Johnson & Johnson (J&J), has an ambitious

X

Johnson & Johnson leads the way to a world without disease

https://pharmaphorum.com/views-analysis-digital/world-without-disease-johnson-johnson-leads/

Digital health round-up: NHS needs more apps, says health secretary

Digital health round-up: NHS needs more apps, says health secretary

Richard Staines presents his weekly round-up of the latest digital health news

X

Digital health round-up: NHS needs more apps, says health secretary

https://pharmaphorum.com/views-and-analysis/digital-health-round-up-nhs-needs-more-apps/

J&J tops the pharma market cap charts – but for how long?

J&J tops the pharma market cap charts – but for how long?

Data and analytics firm GlobalData has tracked the market cap and performance of the top 25 pharma companies

X

J&J tops the pharma market cap charts – but for how long?

https://pharmaphorum.com/views-and-analysis/jj-tops-pharma-market-cap-charts-long/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com